Lilly reiterated by Bear Stearns at peer perform

Eli Lilly & Co. Inc. was maintained by Bear Stearns analyst John Boris at a peer perform rating following the firm's hosted dinner for Lilly's head of research and development and vice president of science and technology. Bear Stearns said they provided some insightful comments, leading to a view that the Street may be under-appreciating efforts on Cymbalta and Forteo. Lilly shares Wednesday were down $0.07, or 0.13%, at $55.45 on volume of 2,483,000 shares versus the three-month running average of 3,582,410 shares.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.